Peer-reviewed veterinary case report
Antibody response to calicivirus vaccine in healthy adult cats
By Bergmann, Michèle et al.·Published in Viruses·2019·Clinic of Small Animal Medicine, Germany·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Antibody Response to Feline Calicivirus Vaccination in Healthy Adult Cats.
- Species:
- cat
Plain-English summary
A group of healthy adult cats that had not been vaccinated for over a year received a vaccine for feline calicivirus (FCV) to see how well they would respond. Before vaccination, about 62% of the cats had some level of FCV antibodies, and after vaccination, only a small percentage showed a significant increase in antibody levels. Factors like age and whether the cat had been vaccinated before influenced the presence of these antibodies. The study found that outdoor cats were more likely to show a strong response to the vaccine. Overall, while many cats had pre-existing antibodies, a strong response to the vaccine was uncommon.
People also search for: cat calicivirus vaccine response · why is my cat vaccinated · feline calicivirus symptoms · outdoor cat vaccination needs · adult cat vaccination schedule
Abstract
This study evaluated the prevalence of feline calicivirus (FCV) antibodies and response to vaccination in healthy adult cats. Cats >1 year (= 111) that had not been vaccinated within 12 months of enrollment in the study received a vaccine containing inactivated FCV antigen strains 431 and G1. Antibodies were determined on Days 0, 7, and 28 by virus neutralization (VN) using FCV isolate KS20, and by broad spectrum blocking FCV enzyme-linked immunosorbent assay (ELISA). Factors associated with the presence of antibodies and vaccine response were determined by uni- and multivariate analysis. Pre-vaccination antibodies were detected in 62.2% of cats (CI: 52.9-70.1) by VN and in 77.2% (CI: 67.5-84.6) by ELISA. A ≥4-fold titer increase after vaccination was observed in 13.6% (CI: 8.3-21.4) of cats with VN and 33.7% (CI: 24.5-44.5) with ELISA. Factors associated with the presence of pre-vaccination VN antibodies were age (≥2 years; OR: 7.091;= 0.022) and lack of previous vaccination (OR: 3.472;= 0.014). The presence of pre-vaccination ELISA antibodies was associated with time since last vaccination (OR: 5.672;= 0.043). Outdoor cats were more likely to have a ≥4-fold ELISA titer increase (OR: 5.556;= 0.005). Many cats had pre-vaccination FCV antibodies, and their presence depended on previous vaccinations and increases with age. A ≥4-fold titer increase was rarely observed and was influenced by the lifestyle of the cat.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/31370359/